News | Artificial Intelligence | February 13, 2019

Siemens Healthineers Demonstrates Artificial Intelligence, Healthcare Digitalization at HIMSS19

Company will showcase AI Companion applications, inventory management software

Siemens Healthineers Demonstrates Artificial Intelligence, Healthcare Digitalization at HIMSS19

February 13, 2019 — At the 2019 Healthcare Information and Management Systems Society (HIMSS) global conference and exhibition, Feb. 11-15 in Orlando, Fla., Siemens Healthineers will demonstrate how healthcare providers can benefit from digitalization, particularly in the form of artificial intelligence (AI). In addition to its greater digital services portfolio, Siemens Healthineers will showcase two AI-based applications, the AI-Pathway Companion and the AI-Rad Companion.

The company will also present various digital solutions that have the potential to both help improve patient care and help reduce costs. These include several information technology (IT) tools for laboratory diagnostics, as well as the syngo Virtual Cockpit, a solution that enables medical professionals to connect remotely to scanner workplaces to assist personnel at a different location.

Siemens is also currently investigating AI-powered Digital Twin technology, which aims to enable the simulation of individual organ physiology to potentially better understand patient health and predict changes and therapy outcomes.

  • The AI-Pathway Companion, which is currently under development, will be a clinical decision support system based on clinical guideline data imported by AI that can aid physicians in making diagnostic and therapeutic decisions along the clinical pathway. While numerous applications in the healthcare market make the workflows of individual clinical or administrative departments more efficient, the AI-Pathway Companion is designed to help optimize the processes along clinical pathways, and thus support personalized as well as standardized patient management. The design goal of the AI-Pathway Companion is to provide physicians in multi-disciplinary disease boards with the clinical status of each patient, based on data integration and artificial intelligence, and to help make recommendations for next steps to accelerate diagnostic and treatment decisions.
  • The AI-Rad Companion Chest CT, which is pending U.S. Food and Drug Administration (FDA) 510(k) clearance, will be the first intelligent software assistant from Siemens Healthineers for radiology – and the first application of the AI-Rad Companion platform. The AI-Rad Companion Chest CT (computed tomography) is designed to identify anatomies and potentially disease-relevant changes, differentiate between various structures and highlight them individually, and mark and measure potential abnormalities. This applies to organs such as the lungs, heart, aorta and coronary arteries. The software is designed to automatically turn findings into a quantitative report.
  • The syngo Virtual Cockpit software solution, which is not yet commercially available, can be used by medical staff to connect remotely to scanner workplaces to assist personnel at a different location, especially where more sophisticated examinations are required. syngo Virtual Cockpit can be utilized with magnetic resonance imaging (MRI) and MR-positron emission tomography (PET) scanners as well as with CT systems from Siemens Healthineers. With the ability to deploy experienced technologists across multiple locations, healthcare providers can achieve a higher level of standardization that can lead to more accurate diagnoses.

For more information: www.usa.healthcare.siemens.com

Related Content

The interior of the German air force Airbus A-310 Medivac in Cologne, Germany, before its departure to Bergamo, Italy, March 28 to being ferrying COVID-19 patients to Germany for treatment to aid the Italians, whose healthcare system has been overwhelmed by the rapid spread of the coronavirus pandemic. Bundeswehr Photo by Kevin Schrief.

The interior of the German air force Airbus A-310 Medivac in Cologne, Germany, before its departure to Bergamo, Italy, March 28 to being ferrying COVID-19 patients to Germany for treatment to aid the Italians, whose healthcare system has been overwhelmed by the rapid spread of the coronavirus pandemic. Bundeswehr Photo by Kevin Schrief. Find more images from the COVID-19 pandemic.

 

Feature | Coronavirus (COVID-19) | April 08, 2020 | By Melinda Taschetta-Millane and Dave Fornell
In an effort to keep the imaging field updated on the latest information being released on coronavirus (COVID-19), th
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2  The first of three clinical scenarios presented to the panel with final recommendations. Mild features refer to absence of significant pulmonary dysfunction or damage. Pre-test probability is based upon background prevalence of disease and may be further modified by individual’s exposure risk. The absence of resource constraints corresponds to sufficient availability of personnel, personal protective equipment, COVID-19 testing, hospital beds, and/or ve

 The first of three clinical scenarios presented to the panel with final recommendations. Mild features refer to absence of significant pulmonary dysfunction or damage. Pre-test probability is based upon background prevalence of disease and may be further modified by individual’s exposure risk. The absence of resource constraints corresponds to sufficient availability of personnel, personal protective equipment, COVID-19 testing, hospital beds, and/or ventilators with the need to rapidly triage patients. Contextual detail and considerations for imaging with CXR (chest radiography) versus CT (computed tomography) are presented in the text. (Pos=positive, Neg=negative, Mod=moderate). [Although not covered by this scenario and not shown in the figure, in the presence of significant resources constraints, there is no role for imaging of patients with mild features of COVID-19.] Image courtesy of the journal Radiology

News | Coronavirus (COVID-19) | April 07, 2020
April 7, 2020 — A multinational consens...
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 Chest CT findings of pediatric patients with COVID-19 on transaxial images. (a) Male, 2 months old, 2 days after symptom onset. Patchy ground-glass opacities GGO in the right lower lobe

Chest CT findings of pediatric patients with COVID-19 on transaxial images. Male, 2 months old, 2 days after symptom onset. Patchy ground-glass opacities GGO in the right lower lobe. Image courtesy of Radiology: Cardiothoracic Imaging

News | Coronavirus (COVID-19) | April 06, 2020
April 6, 2020 — Children and teenagers with COVID-19...
A recent study earlier this year in the journal Nature, which included researchers from Google Health London, demonstrated that artificial intelligence (AI) technology outperformed radiologists in diagnosing breast cancer on mammograms
Feature | Breast Imaging | April 06, 2020 | By Samir Parikh
A recent study earlier this year in the journal Nature,
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 Sonogram taken under rib cage shows liver (grey) with curved diaphragm-lung border (white). Arrows point to vertical B lines (white) demonstrating diseased lung tissue. The more B lines the worse the disease. Healing is measured by reduction in the number of B lines.

Sonogram taken under rib cage shows liver (grey) with curved diaphragm-lung border (white). Arrows point to vertical B lines (white) demonstrating diseased lung tissue. The more B lines the worse the disease. Healing is measured by reduction in the number of B lines.

News | Coronavirus (COVID-19) | April 06, 2020
April 6, 2020 — Robert L.
Varian received FDA clearance for its Ethos therapy in February 2020. It is an adaptive intelligence solution that uses onboard AI in the treatment system to take the cone beam CT imaging on the system, compare it to the treatment plan and deliver an entire adaptive treatment plan in a typical 15-minute treatment time slot, from patient setup through treatment delivery.

Varian received FDA clearance for its Ethos therapy in February 2020, shown here displayed for the first time at ASTRO 2019. It is an adaptive intelligence solution that uses onboard AI in the treatment system to take the cone beam CT imaging on the system, compare it to the treatment plan and deliver an entire adaptive treatment plan in a typical 15-minute treatment time slot, from patient setup through treatment delivery.

Feature | Treatment Planning | April 03, 2020 | Dave Fornell, Editor
The traditional treatment planning process takes days to create an optimized radiation therapy delivery plan, but new
Recommended best practices for nuclear imaging departments under the COVIF-19 pandemic have been issues by the ASNC and SNMMI. #COVID19 #ASNC #SNMMI #Coronavirus #SARScov2
News | Coronavirus (COVID-19) | April 03, 2020
April 3, 2020 — A new guidance document on best practices to maintain safety and minimize contamination in nuclear im